Human Iron Research at Oxford (HIRO)
Generous, unrestricted funding support from Vifor Pharma has driven the creation of Human Iron Research at Oxford (HIRO), a new initiative looking to link clinicians and scientists with an interest in iron research across the Oxford campus. Iron is implicated in a broad range of disorders, including anaemia and cancer, inflammation and infection, gastrointestinal and endocrine diseases, and nutrition and the microbiome, and HIRO will promote and facilitate translational iron research in these areas. HIRO, led by Dr John Ryan (TGU) and Prof Hal Drakesmith (WIMM), will provide pump-prime funding support, and a 3-year post-doc iron research fellow will be appointed.
For more information please contact email@example.com
HIRO Internal Funding Stream
The second funding call from HIRO will open on 1st August 2019, with a deadline of Monday 30th September 2019. Please email your completed application form to Georgina Kerr (firstname.lastname@example.org).
Remit and scope of the funding stream
Projects will need to demonstrate a fit with one or more of the following HIRO strategic priorities:
- Excellent, novel, human-focussed translational iron research
- Cross-disciplinary and cross-departmental research
- Research for patient benefit
Projects can aim to generate preliminary data or build on existing research. Projects should be no longer than 12 months duration. Applications from early-stage career researchers are particularly welcomed. Staff costs are not eligible.
Launch of HIRO (past event)
Wednesday 12th September, 2018, 14.00- 17.00, Examination Schools, High St, Oxford
This was an opportunity for anyone involved in iron research at Oxford to present their current work, meet other iron researchers and also for those who wished to apply for HIRO pump priming funding to come and present their ideas.